Main content
This programme is not currently available on Βι¶ΉΤΌΕΔ iPlayer

Bittersweet Medicine

A toddler with a rare condition has become the first child treated in the UK with a life-saving gene therapy. The drug costs Β£3m per patient. Βι¶ΉΤΌΕΔ medical editor Fergus Walsh has this exclusive report.

A toddler with a rare and devastating inherited condition has become the first child to be treated in the UK with a life-saving gene therapy. The drug, called Libmeldy, is the most expensive medicine in Europe, costing nearly Β£3m per patient. For the family it is bittersweet as only one of the two children can be saved. The Βι¶ΉΤΌΕΔ’s medical editor Fergus Walsh has followed the treatment at Royal Manchester Children’s Hospital over several months and has this exclusive report.

30 minutes

Last on

Mon 20 Feb 2023 03:30GMT

Broadcasts

Featured in...